{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:48:56Z","timestamp":1775728136878,"version":"3.50.1"},"reference-count":20,"publisher":"Impact Journals, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,4,20]]},"DOI":"10.18632\/oncotarget.3562","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T07:00:46Z","timestamp":1442300446000},"page":"9592-9599","source":"Crossref","is-referenced-by-count":13,"title":["Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy"],"prefix":"10.18632","volume":"6","author":[{"given":"Peng","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Radiotherapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,3,12]]},"reference":[{"issue":"6","key":"1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","article-title":"Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group","volume":"230","author":"Wils","year":"1999","journal-title":"Ann Surg"},{"issue":"13","key":"2","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1200\/JCO.2008.19.7921","article-title":"Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review","volume":"27","author":"Azria","year":"2009","journal-title":"J Clin Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1385\/IJGC:34:2-3:107","article-title":"Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas","volume":"34","author":"Tempero","year":"2003","journal-title":"Int J Gastrointest Cancer"},{"issue":"3","key":"4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ijrobp.2006.12.053","article-title":"Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer","volume":"68","author":"Ben-Josef","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"31","key":"5","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","article-title":"Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial","volume":"29","author":"Benson","year":"2011","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jprot.2012.09.025","article-title":"Strategies for discovering novel pancreatic cancer biomarkers","volume":"81","author":"Blasutig","year":"2013","journal-title":"J Proteomics"},{"issue":"6","key":"7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/PPO.0b013e31827654ea","article-title":"Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive","volume":"18","author":"Winter","year":"2012","journal-title":"Cancer J"},{"issue":"36","key":"8","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1200\/JCO.2008.18.6288","article-title":"Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704","volume":"26","author":"Willett","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejso.2006.10.004","article-title":"Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer","volume":"33","author":"Siriwardena","year":"2007","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00432-014-1601-y","article-title":"CEA\/CA72-4 levels in peritoneal lavage fluid are predictive factors in patients with gastric carcinoma","volume":"140","author":"Ishida","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"11","first-page":"537","article-title":"Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors","volume":"47","author":"Burges","year":"2009","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000077438","article-title":"Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer","volume":"66","author":"Haglund","year":"2004","journal-title":"Oncology"},{"issue":"2","key":"13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5301\/JBM.5000023","article-title":"Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer","volume":"28","author":"Cunzhi","year":"2013","journal-title":"Int J Biol Markers"},{"issue":"3","key":"14","first-page":"464","article-title":"Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer","volume":"3","author":"Zou","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"2","key":"15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3892\/mco.2013.226","article-title":"Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma","volume":"2","author":"Tian","year":"2014","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10120-013-0259-5","article-title":"Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association","volume":"17","author":"Takahashi","year":"2014","journal-title":"Gastric Cancer"},{"issue":"4","key":"17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jaut.2008.08.008","article-title":"Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices","volume":"31","author":"Kiss","year":"2008","journal-title":"J Autoimmun"},{"issue":"4","key":"18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4149\/neo_2012_053","article-title":"Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell","volume":"59","author":"Liu","year":"2012","journal-title":"Neoplasma"},{"key":"19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bios.2014.08.043","article-title":"Ultrasensitive electrochemical immunosensor for carbohydrate antigen 72-4 based on dual signal amplification strategy of nanoporous gold and polyaniline-Au asymmetric multicomponent nanoparticles","volume":"64","author":"Wei","year":"2015","journal-title":"Biosens Bioelectron"},{"issue":"10","key":"20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jnci\/djs208","article-title":"TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study","volume":"104","author":"Wiedenmann","year":"2012","journal-title":"J Natl Cancer Inst"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T11:27:06Z","timestamp":1589369226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,12]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,4,20]]}},"alternative-id":["3562","25860937"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.3562","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,12]]}}}